ATC code L01
Abemaciclib
Aclarubicin
Adagrasib
Adenosine deaminase inhibitor
Adverse effect (medicine)
Aflibercept
Alitretinoin
Alkyl sulfonate
Alkylating antineoplastic agent
Alopecia
Alpelisib
Altretamine
Alvocidib
American Society of Health-System Pharmacists
Aminolevulinic acid
Aminopterin
Amrubicin
Amsacrine
Anagrelide
Anaphylaxis
Anatomical Therapeutic Chemical Classification System
Anthracycline
Anthraquinone
Antifolate
Antimetabolite
Antineoplastic
Arsenic trioxide
Asparaginase
Asparagine
Atrasentan
Axicabtagene ciloleucel
Azacitidine
Aziridine
Bacterium
Belinostat
Belotecan
Belzutifan
Bendamustine
Bexarotene
Bibcode (identifier)
Bioavailability
Biological half-life
Bisantrene
Bleomycin (data page)
Bortezomib
Boxed warning
Brexucabtagene autoleucel
Bristol-Myers Squibb
Busulfan
CAS Registry Number
Cabazitaxel
Camptotheca
Camptothecin
Cancer
Capecitabine
Carboplatin
Carboquone
Carfilzomib
Carmofur
Carmustine
Celecoxib
Cell-cycle nonspecific antineoplastic agents
Cellular senescence
Cervical cancer
ChEBI
ChEMBL
Chelation
ChemSpider
Chemical formula
Chemotherapy
Chest X-rays
Chlorambucil
Chlormethine
Ciltacabtagene autoleucel
Cisplatin
Cladribine
Clinical trial
Clofarabine
CompTox Chemicals Dashboard
Copanlisib
Cositecan
Criegee rearrangement
Crisnatol
Crosslinking of DNA
Cyclin-dependent kinase
Cyclophosphamide
Cytarabine
DNA
DNA polymerase inhibitor
DNA replication
Dacarbazine
Dactinomycin
DailyMed
Daunorubicin
Daunorubicin/cytarabine
Decitabine
Demecolcine
Denileukin diftitox
Deoxyribonucleotide
Dermatographism
Dicycloplatin
Dihydrofolate reductase inhibitor
Docetaxel
Doi (identifier)
Doxifluridine
Doxorubicin
DrugBank
Drug class
Drug nomenclature
Drugs.com
Duvelisib
Efaproxiral
Eflornithine
Elesclomol
Elsamitrucin
Enasidenib
Endothelin receptor antagonist
Entinostat
Enzyme inhibitor
Epacadostat
Epirubicin
Epothilone
Eribulin
Estramustine phosphate
Etirinotecan pegol
Etoglucid
Etoposide
European Medicines Agency
Exatecan
Excretion
FDA
Farnesyltransferase inhibitor
Fever
Flagellate pigmentation from bleomycin
Floxuridine
Fludarabine
Fluorouracil
Food and Drug Administration
Fotemustine
Free radicals
Fuzuloparib
Gemcitabine
General anaesthesia
Generic medication
Gimatecan
Glasdegib
Halogenation
Hamao Umezawa
Hdl (identifier)
Histone deacetylase inhibitor
History of cancer chemotherapy
Hodgkin's disease
Hodgkin's lymphoma
Hydrazine
Hydroxycarbamide
Hyperpigmentation
Hypogeusia
Hypomethylating agent
IL-1beta
IMP dehydrogenase
ISBN (identifier)
IUPAC nomenclature of chemistry
Idarubicin
Idecabtagene vicleucel
Idelalisib
Ifosfamide
Imetelstat
Inavolisib
Intercalation (biochemistry)
Interleukin 18
International Chemical Identifier
Intramuscular injection
Intravenous therapy
Irinotecan
Isocitrate dehydrogenase
Ivosidenib
Ixabepilone
Ixazomib
JSmol
KEGG
Kidney
Larotaxel
Lifileucel
Lipoxygenase inhibitor
Lisocabtagene maraleucel
List of withdrawn drugs
Lomustine
Lonidamine
Losoxantrone
Lucanthone
Lurbinectedin
Lurtotecan
M phase
Mannosulfan
Masoprocol
MedlinePlus
Melphalan
Melphalan flufenamide
Menogaril
Mercaptopurine
Methotrexate
Methyl aminolevulinate
Microtubule
Mitobronitol
Mitoguazone
Mitomycins
Mitotane
Mitotic inhibitor
Mitoxantrone
Mitozolomide
Molar mass
Nadofaragene firadenovec
Navitoclax
Nedaplatin
Nelarabine
Nimustine
Nippon Kayaku
Niraparib
Niraparib/abiraterone acetate
Nitrogen mustard
Nitrosourea
Non-Hodgkin's disease
Non-Hodgkin's lymphoma
Obecabtagene autoleucel
Oblimersen
Olaparib
Olutasidenib
Omacetaxine mepesuccinate
Oprozomib
Ortataxel
Ovarian cancer
Oxaliplatin
Oxygen toxicity
PARP inhibitor
PMC (identifier)
PMID (identifier)
Paclitaxel
Padeliporfin
Palbociclib
Panobinostat
Pegaspargase
Pemetrexed
Pentostatin
Pharmacokinetics
Phases of clinical research
Phosphodiesterase inhibitor
Phosphoinositide 3-kinase inhibitor
Photodynamic therapy
Photosensitizer
Pingyangmycin
Pipobroman
Pirarubicin
Pixantrone
Platinum-based antineoplastic
Pleural cavity
Pleural effusion
Pleurodesis
Plicamycin
Plitidepsin
Pneumonitis
Podophyllum peltatum
Porfimer sodium
Porphyrin
Pralatrexate
Prednimustine
Pregnancy category
Prescription drug
Procarbazine
Proinflammatory cytokine
Proteasome inhibitor
Protein kinase inhibitor
PubChem
Pulmonary fibrosis
Purine analogue
Pyrimidine analogue
Rabacfosadine
Raltitrexed
Ranimustine
Raynaud's phenomenon
Receptor antagonist
Regulation of therapeutic goods
Retinoid
Retinoid X receptor
Ribociclib
Ribonucleotide reductase inhibitor
Romidepsin
Route of administration
Rubitecan
Rucaparib
S2CID (identifier)
S phase
Satraplatin
Scuba diving
Seliciclib
Selinexor
Semustine
Sex steroid
Side effects
Silatecan
Simplified molecular-input line-entry system
Sitimagene ceradenovec
Sotorasib
Spindle poison
Streptomyces
Streptomyces verticillus
Streptozotocin
Subcutaneous injection
Tabelecleucel
Tagraxofusp
Talaporfin
Talc
Talimogene laherparepvec
Taxane
Tazemetostat
Tebentafusp
Tegafur
Tegafur/gimeracil/oteracil
Temoporfin
Temozolomide
Teniposide
Tesetaxel
Testicular cancer
Testolactone
Thiopurine
Thiotepa
Thymidine
Thymidylate synthase inhibitor
Tiazofurin
Tiazofurine
Tigilanol tiglate
Tioguanine
Tipifarnib
Tisagenlecleucel
Topoisomerase inhibitor
Topotecan
Trabectedin
Treosulfan
Tretinoin
Triazene
Triaziquone
Triethylenemelamine
Trofosfamide
Type II topoisomerase
Type I topoisomerase
Umbralisib
Unique Ingredient Identifier
Uramustine
Valrubicin
Veliparib
Venetoclax
Verdinexor
Verteporfin
Vinblastine
Vinca alkaloid
Vincristine
Vindesine
Vinflunine
Vinorelbine
Vorasidenib
Vorinostat
Vosaroxin
WHO Model List of Essential Medicines
World Health Organization
Zorubicin